Showing 7781-7790 of 10548 results for "".
- GlobalSkin’s GRIDD Study to Measure True Impact of Skin Diseases Across the Globehttps://practicaldermatology.com/news/globalskins-gridd-study-to-measure-true-impact-of-skin-diseases-across-the-globe/2461856/The International Alliance of Dermatology Patient Organizations (GlobalSkin), in partnership with Cardiff University (UK), and University Medical Centre Hamburg-Eppendorf (Germany), launched the Global Research on the
- AD Pipeline Watch: Alphyn Biologics’ Topical AB-101Shows Promise in Phase 2a Studyhttps://practicaldermatology.com/news/ad-pipeline-watch-alphyn-biologics-topical-ab-101shows-promise-in-phase-2a-study/2461852/
- VisualDx, Vaseline Join Forces to Advance Education on Treating Skin of Colorhttps://practicaldermatology.com/news/visualdx-vaseline-join-forces-to-advance-education-on-treating-skin-of-color/2461817/VisualDx and
- DFD-29 Shows No Major impact on Healthy Microbial Flora in Rosaceahttps://practicaldermatology.com/news/dfd-29-shows-no-major-impact-on-healthy-microbial-flora-in-rosacea/2461785/DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) doesn’t disrupt the microbial floral in healthy adults with papulopustular rosacea, according to data from a Phase 1 clinical trial. DFD-29 is being developed for the treatment of papulopustular ros
- HEROES Educational Campaign Highlights Role of Salons in Promoting Skin and Scalp Healthhttps://practicaldermatology.com/news/heroes-educational-campaign-highlights-role-of-salons-in-promoting-skin-and-scalp-health/2461766/The Globa
- Positive Results Seen for Alphyn’s AB-101 in Kids with ADhttps://practicaldermatology.com/news/positive-pediatric-results-seen-for-alphyns-ab-101-in-ad/2461700/
- PathologyWatch Launches ‘Show Me Some Skin’ Campaign for Skin Cancer Awareness Monthhttps://practicaldermatology.com/news/pathologywatch-launches-show-me-some-skin-campaign-for-skin-cancer-awareness-month/2461696/
- USPSTF Final Recommendation: There’s Not Enough Evidence to Support Skin Cancer Screening in Folks Without Symptomshttps://practicaldermatology.com/news/uspstf-final-recommendation-theres-not-enough-evidence-to-support-skin-cancer-screening-in-folks-without-symptoms/2461665/
- Almirall to Assess Wellbeing in Psoriasis Studyhttps://practicaldermatology.com/news/almirall-to-assess-wellbeing-in-psoriasis-study/2461658/
- PHC Corporation, NovaScan Collab Set to Explore NMSC Detection Devicehttps://practicaldermatology.com/news/phc-corporation-novascan-collab-set-to-explore-nmsc-detection-device/2461644/PHC Corporation and